Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Enzyme Inhibition|January 1, 1994
Evaluation of some 4-fluoro- and 4-cyano derivatives of delta 4,3-ketosteroids as inhibitors of testosterone 5 alpha-reductaseM Jarman, S E Barrie, J Houghton, et al.European Journal of Medical Genetics|December 16, 2014
Long-term change of disease behavior in Papillon-Lefèvre syndrome: seven years follow-upXinwen Wang, Yang Liu, Yuan Liu, et al.Journal of Medicinal Chemistry|October 13, 1995
Esters of 3-pyridylacetic acid that combine potent inhibition of 17 alpha-hydroxylase/C17,20-lyase (cytochrome P45017 alpha) with resistance to esterase hydrolysisM G Rowlands, S E Barrie, F Chan, et al.Compendium of Continuing Education in Dentistry (Jamesburg, N.J. : 1995)|January 16, 2003
Bovine-derived bone protein extract in the treatment of mandibular Class II furcationsPaulo M Camargo, Lawrence E Wolinsky, Ann V Burgess, et al.Journal of Medicinal Chemistry|August 16, 1996
3- and 4-pyridylalkyl adamantanecarboxylates: inhibitors of human cytochrome P450(17 alpha) (17 alpha-hydroxylase/C17,20-lyase). Potential nonsteroidal agents for the treatment of prostatic cancerF C Chan, G A Potter, S E Barrie, et al.The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1997
Biochemistry and pharmacokinetics of potent non-steroidal cytochrome P450(17alpha) inhibitorsS E Barrie, B P Haynes, G A Potter, et al.Glia|December 31, 2004
Characterization of the murine splice variant Mobp155: developmental CNS expression pattern and subcellular localization of epitope-tagged proteinPaul Montague, Andrew S McCallion, Jennifer E Barrie, et al.European Journal of Cancer & Clinical Oncology|May 1, 1986
5-Ethyl-2'-deoxyuridine: an explanation for its lack of cytotoxic action in vivoA Jeney, S E Barrie, G A Taylor, et al.Pageof 4